Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 og 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 og 5.

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

bayer a/s* - levonorgestrelum inn - leginnlegg - 19.5 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

gilead sciences ireland uc* - amphotericinum b inn - innrennslisstofn, ördreifa - 50 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

gedeon richter plc.* - progesteronum inn - leggangastíll - 400 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

merck ab - progesteronum inn - leggangahlaup - 8 %

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

bayer ab - levonorgestrelum inn - leginnlegg - 13,5 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

bayer ab* - levonorgestrelum inn - leginnlegg - 20 míkróg/24 klst.

Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

curium pet france - piflufolastat (18f) - blöðruhálskirtli - greining geislavirkja - Þetta lyf er eingöngu ætlað til greiningar. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).